Aurinia Pharmaceuticals Inc banner

Aurinia Pharmaceuticals Inc
F:IKAP

Watchlist Manager
Aurinia Pharmaceuticals Inc Logo
Aurinia Pharmaceuticals Inc
F:IKAP
Watchlist
Price: 13.075 EUR -3.18% Market Closed
Market Cap: €1.9B

Multiples-Based Value

The Multiples-Based Value for Aurinia Pharmaceuticals Inc (IKAP) under the Base Case is 7.708 EUR. Compared with the current market price of 13.075 EUR, the stock appears Overvalued by 41% .

Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

IKAP Multiples-Based Value
7.708 EUR
Overvaluation 41%
Multiples-Based Value
Price €13.075
Bear Case
Base Case
Bull Case

Multiples Across Competitors

IKAP Competitors Multiples
Aurinia Pharmaceuticals Inc Competitors

Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett